BackRepliCel Life Sciences Overview

RepliCel Life Sciences Total Assets

Latest total assets for REPCF: $170K.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$172679.00
↓ 65.16% YoYΔ $-322970.00 vs prior year quarter

Peer trimmed avg / median

Loading

RepliCel Life Sciences Total Assets History

Loading

RepliCel Life Sciences vs. peers: Total Assets Comparison

Loading

RepliCel Life Sciences Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

RepliCel Life Sciences (REPCF) FAQ

The latest total assets for REPCF is $170K as of June 2024. That compares with $500K in the prior-year period — down 65.2% year over year. Investors often review this figure alongside RepliCel Life Sciences's historical trend and sector peers before judging valuation or financial health.

Over the past year, REPCF's total assets moved from $500K to $170K — a 65.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in RepliCel Life Sciences's operating scale or balance-sheet position.

A total assets figure of $170K for REPCF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting REPCF's total assets ($170K), review year-over-year change from $500K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack RepliCel Life Sciences's total assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.